Praised for its ‘remarkable knowledge’ of the biotech industry, HBC Avocats acts for a diverse client roster of life sciences-focused venture capital firms, biotech corporates, and clients active within the agricultural biotech space. Practice co-lead Jonathan Burnham is well known for his expansive knowledge of global licensing and collaboration agreements, and sublicence agreements. Co-head Erwan Cossé has broad experience in the full range of corporate matters within the health care and life sciences sector, often advising on investment agreements.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
‘Jonathan Burnham is my go-to person to discuss tricky situations with ongoing licence or collaboration contracts.’
‘HBC Avocats is excellent in the field of business advice for biotechnology companies. The entire team is particularly experienced in this field and I can only recommend it. I have in mind several situations where the firm has been very creative and has helped to unblock complicated situations. Finally, the availability and commitment of the team is excellent.’
Key clients
- Adcytherix
- Eukarÿs
Work highlights
Advised Emergence Therapeutics, a French and German biotech company focused on the development of antibody-drug conjugate cancer drugs, on French law matters in connection with structuring and negotiating its sale to the US pharmaceutical company Eli Lilly.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Jonathan Burnham; Erwan Cossé
Other key lawyers
Fabrice Herbin